Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.

Trabulo, S; Cardoso, A M; Santos-Ferreira, T; Cardoso, A L; Simões, S; Pedroso de Lima, M C

Trabulo, S; Cardoso, A M; Santos-Ferreira, T; Cardoso, A L; Simões, S; Pedroso de Lima, M C.

Affiliation

Trabulo S; Center for Neuroscience and Cell Biology of Coimbra, Faculty of Science and Technology, University of Coimbra, Portugal.

Mol Pharm ; 8(4): 1120-31, 2011 Aug 01.

Article in En | MEDLINE | ID: mdl-21619051

Subject(s)

Doxorubicin/pharmacology; Inhibitor of Apoptosis Proteins/metabolism; Antibiotics, Antineoplastic/pharmacology; Antineoplastic Agents, Phytogenic/pharmacology; Apoptosis/drug effects; Apoptosis/genetics; Blotting, Western; Caspase 3/metabolism; Caspase 7/metabolism; Cell Line, Tumor; Cell Survival/drug effects; Cell Survival/genetics; Flow Cytometry; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins/genetics; RNA, Small Interfering/genetics; RNA, Small Interfering/physiology; Reverse Transcriptase Polymerase Chain Reaction; Survivin; Vinblastine/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Inhibitor of Apoptosis Proteins Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2011 Type: Article Affiliation country: Portugal

Fulltext

XML

PubMed Links

Search on Google